INTERNATIONAL PATENT: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD., 博瑞生物医药（苏州）股份有限公司, BRIGHTGENE PHARMACEUTICAL (SUZHOU) CO. LTD., 博瑞制药（苏州）有限公司 FILES APPLICATION FOR "PREPARATION METHOD FOR DUAL GIP AND GLP-1 RECEPTOR AGONIST"

Posted On: 2025-05-11

GENEVA, May 11 -- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (Building C25, No.218 Xinghu Street, Bio-Bay Suzhou Industrial ParkSuzhou, Jiangsu 215123), 博瑞生物医药（苏州）股份有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物纳米园C25栋), BRIGHTGENE PHARMACEUTICAL (SUZHOU) CO. LTD. (Building C25, Building C26, Building C27, Building C28, No.218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 博瑞制药（苏州）有限公司...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD., 博瑞生物医药（苏州）股份有限公司, BRIGHTGENE PHARMACEUTICAL (SUZHOU) CO. LTD., 博瑞制药（苏州）有限公司 FILES APPLICATION FOR "PREPARATION METHOD FOR DUAL GIP AND GLP-1 RECEPTOR AGONIST"